Curatio Networks Inc. (RxPx)

https://curatio.me/

Visit website

RxPx is positioned as the only end-to-end digital health system that combines clinical monitoring, AI-driven smart adherence, human nursing support, and peer-to-peer engagement to support healthcare providers and patients on complex and specialty therapies. Built around a “No Patient Alone” mission, RxPx helps life sciences teams and care providers deliver safer, more supportive therapy experiences, while reducing operational burden through integrated, configurable workflows.

Designed specifically for the highly regulated requirements of pharma, RxPx operationalizes patient safety and risk management, adherence, and psychosocial support across the full journey: during clinical trials, at therapy initiation, and throughout long-term treatment. The platform’s automated and integrated clinical workflows enable multi-channel patient engagement, helping brands and care programs maximize ROI for therapy launch and growth, while maintaining consistency and governance across regions and sites.

For healthcare professionals and care teams, RxPx provides a secure HCP platform with scalable, configurable workflows for prescribing, onboarding, and monitoring medicines, helping turn hours of administrative work into minutes, reducing portal fatigue, and supporting interventions and educated conversations between HCPs and patients. For patients and caregivers, RxPx offers adherence tools (e.g., reminders and tracking), evidence-based education, and community features that support peer connection. Personalization is delivered through a hybrid model that blends an in-platform live Community Manager with a conversational interface that guides each individual’s journey based on questions, tracked behaviors, and responses. RxPx also integrates services commonly required in specialty programs, such as nurse support and lab monitoring, into one streamlined digital solution.

Used globally (RxPx states availability in 12 languages and in over 100 countries, including “over 120 countries”), RxPx supports global deployment while still enabling local program needs. As part of its clinical platform roadmap, RxPx is launching the AI Clinical Platform System to strengthen clinical trial performance by improving recruitment and diversity, increasing adherence and retention, enhancing physical and behavioral tracking, and reducing operational overhead, within a privacy- and compliance-oriented environment. 

 

https://rxpx.health/

Main Contacts

Alireza Davoodi

VP of Research and Development, Curatio (RxPx)